newsfilter
← Latest News
PR Newswire·

BioVaxys Announces Results from The Ohio State University Pan-Sarbecovirus Animal Study

VANCOUVER, BC, Dec. 16, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE:BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") announced today that possibly based on the selected study design, results from